Armand Butera

Investigators believe the current climate crisis can lead to an increased risk of COPD exacerbations and mortality rates, both of which have been noted in prior research.

In an interview with HCPLive, Rosenberger mentioned that every conversation with a patient is an opportunity to educate them on their potential allergies and treatment methods, especially at a time when concerns regarding the delta variant are prominent.

A new study sheds light on some of the atopic disease risks that are associated with early childhood and continue into midlife.

Investigators push for a greater understanding of the disease in relation to the mental health of young patients, which has affected roughly 20% of the global pediatric population.

The US Food and Drug Association are also requiring new and updated warnings for baricitinib and upadacitinib, 2 other arthritis medicines in the same drug class as tofacitinib.

Investigators urge patients undergoing hemodialysis to adhere to their COVID-19 vaccination schedules, as data show a low antibody response.

Investigators believe the ALDORADO trial could properly diagnose the accuracy of open food challenges in comparison to the traditionally used double-blind placebo-controlled food challenge in pediatric patients with food allergies.

Investigators hope that the emerging method of managing these atopic diseases can help remove racial and socioeconomic barriers to care.

Despite conflicting data, investigators form Spain found that gastroesophageal reflux disease and asthma are bidirectional, with each disease exacerbating each other.

Investigators report that the small number of adverse events from the vaccine were successfully treated, with the remaining participants experiencing no allergic responses.

Despite conflicting evidence surrounding older patient populations, investigators found no age-specific treatment effects on major cardiovascular outcomes.

Recent phase 3 trial data confirms that dupilumab is the first biologic medicine is the first to reduce severity and symptoms of atopic dermatitis in pediatric patients.

Investigators find that substitute salt better protects older people with a history of stroke or high blood pressure against secondary outcomes of cardiovascular events and death.

A recent study found no benefits of immediate angiography over a delayed or selective strategy with respect to the 30-day risk of death from any cause.

Investigators argue that outdated practice laws and other methods hinder physician assistants and nurse practitioners from providing the best patient care and utilizing their skills during the COVID-19 pandemic.

The authors of a recent review recommend continued research on “powerful” new treatment methods that are effective in treating atopic diseases such as atopic eczema.

Investigators believe their study shows the efficacy and safety of the 2 biologic agents, which are known to have anti-inflammatory and immunosuppressant qualities.

Investigators have found a negative association between the COPD and proton pump inhibitors through a familiar sequence symmetry analysis approach used to find associations between COPD and gastro-esophageal reflux disease.

Though operating room-based injections are predominantly performed, investigators could not find sufficient data that confirmed it as the only safe injection site.

The new growth hormone has a weekly injection rate, as opposed to the daily injection rates of other growth hormones such as somatropin.

The investigative team in Canada found that pre-pregnancy weight may possibly influence a child’s risk of developing pediatric allergic diseases.

Investigators believe the treatment strategy can go on to treat other “difficult-to-treat” areas of the body such as palms, elbows, and lips.

A new study shows that research and educational resources are greatly lacking regarding skin color and dermatology education.

Though investigators called for more research on the biologic, recent data showed patients treated with bimekizumab recorded improved skin pain when compared to placebo and adalimumab.

Investigators found that intralymphatic immunotherapy of was not superior to placebo or other forms of allergen-specific immunotherapy, but felt continued research was warranted.

Investigators found that despite a lack of infrastructure on pediatric quality improvement, higher-performing hospitals can sustain cost-effective strategies for pediatric asthma care.

Investigators write that methods such as dermatoscopy can result in early recognition of unstable patches and lead to appropriate medical treatment for patients with vitiligo.

The good care practices cited in the study can lead to increased care of patients with atopic dermatitis and are able to be implemented in any practice.

Developed by BrainsWay, the new device has been shown to decrease anxiety symptoms in adult patients with anxious depression.

Investigators found that children with antibiotic allergy labels have longer hospital stays and increased symptoms of allergic reaction.